AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06400953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stabilization Exercises
Description: Core Stabilization Exercise Program in groups of 8-10 people, for 40 minutes, 2 days a week, for 8 weeks.These exercises included a 5-minute active warm-up, a 30-minute Core Stabilization exercise that included upper and lower extremity movements, and immediately followed by a 5-minute cool-down exercise.The exercises are pilates-based and in the first stage of the program. Movements were performed in standing and sitting positions.Movements were started with 6-8 repetitions, increased by 1-2 repetitions each week, and in the last week, 12-15 repetitions were performed, with contraction times increasing from 5 seconds to 10 seconds. As the exercises progressed from easy to difficult, from simple movements to complex movements, the movements were continued by adding an elastic band and 0.5 kg weight.While advancing the exercise program, the exercises were personalized by taking into account the individual's strain levels.
Study NCT04958174 — intervention group
Intervention type: DEVICE
Intervention: web-application
Description: web application for monitoring children's development
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R1: Reference Product X
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T1: Test Product M
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2: Test Product N
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T3: Test Product O
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T4: Test Product O
Description: under fed conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R2: Reference Product Y
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T5: Test Product P
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T6: Test Product P
Description: under fed conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T7: Test Product Q
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R3: Reference Product Z
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T8: Test Product S
Description: under fasted conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T9: Test Product S
Description: under fed conditions
Study NCT04926246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T10: Test Product U
Description: under fasted conditions
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK117
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine tablets
Description: Oral,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: IV infusion,Specified dose on specified days
Study NCT05235542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU
Description: IV infusion,Specified dose on specified days
Study NCT05009758 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pregnancy test
Description: In female patients, pregnancy will be excluded with a standard urine pregnancy test at the beginning of the main visit.
Study NCT05152771 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: KETOGENIC DIET
Description: This will be a prospective cohort study. All families with children who have been newly diagnosed with confirmed SSPE (based on Dyken's Criteria) will be approached to start the low glycemic index diet (liberalized kind of KD). A thorough dietary history will be taken from the parents/caregivers, and they will be counseled by a trained dietitian on the diet, all pros and cons, and the format. After the verbal agreement, formal consent will be taken from the parent/ caregiver for initiation of the diet.~These patients are usually already admitted in the hospital for initial diagnosis and management. Therefore the initiation of the diet will be in the hospital during their admission if the parents/ caregivers agrees. A minimum of 2-3 days would be required to train the parents/caregivers.
Study NCT05137769 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Body Scan
Description: The body scan is a core element of mindfulness-based stress reduction. Participants will listen to a 20-minute audio guide instructing them to focus on sensations in the body, place attention on one area of the body at a time, and progressively move attention throughout areas of the body.
Study NCT06189924 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Proteomic analysis of exhaled breath condensate
Description: Mechanically ventilated intensive care patients will be sampled for exhaled breath condensate from the ventilator circuit.
Study NCT05009758 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical history of patients, demographic data, concomitant medication, questionnaire
Description: Patients will be asked for their medical history including demographic data and concomitant medication. Details will be noted in the source data file. Furthermore, patients will receive a questionnaire including tools to assess QOL impairment by CRS and asthma
Study NCT05836168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Omnibiotic Stress Repair
Description: multispecies probiotic
Study NCT05836168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05009758 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: UPSIT smell test
Description: University of Pennsylvania Smell Identification Test (UPSIT) smell test will be performed by the patients during the study. It consists of 40 questions in 4 different booklets. The patient needs to scratch a sniff strip with the microencapsulated odorant using a pencil and mark his choice on four-choice multiple-choice questions. The test is then scored by the study team out of the 40 items.
Study NCT05009758 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spirometry
Description: Lung function will be measured by spirometry in the lung function unit of the Department of Pulmonology. Spirometry will be performed according to American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines by authorized and properly certified personal.
Study NCT05009758 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: FeNO
Description: Airway inflammation will be evaluated using a standardized single-breath FeNO test in accordance with the lung function unit of the Department of Pulmonology. A single exhalation technique recommended by the manufacturer will be followed. The FeNO measurements will not be performed within 2 weeks of a respiratory infection. The FeNO test will be performed prior to spirometry. Subjects should not eat or drink 1 hour prior to having the FeNO test. Subjects should not use their rescue SABA medication (e.g., albuterol/salbutamol) within 6 hours of the measurement. Inhaled bronchodilators (including ICS/LABA) should be withheld for the effect duration specific to the bronchodilator. If not, the assessment should be postponed till after the required time has passed since the meal or drink or bronchodilator inhalation. The NIOX VERO® Airway Inflammation Monitor will be used to measured FeNO in the lung function unit of the Department of Pulmonology.
Study NCT05009758 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lung X-Ray
Description: After the bronchoscopy, a lung x-ray will be performed and patients will stay overnight in the ward of the Department of Pulmonology.
Study NCT06175052 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: Four nutrition counselling sessions conducted over eight weeks, in conjunction with food items to assist in meal preparation and with weekly educational information messages sent via email.
Study NCT05479240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Participants will receive Tislelizumab, 200mg, intravenously over 30 - 60 minutes, day 1 of every 3 weeks for 6 cycles.
Study NCT05479240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Participants will receive Capecitabine, 1000mg/m2, day 1-14 of every 3 weeks for 6 cycles
Study NCT05084118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Landiolol HCl
Description: continous 2mcg/kg/min low dose application of Landiolol HCl for 72 hours
Study NCT05479240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: Participants will receive oxaliplatin, 130mg/m2, day 1 of every 3 weeks for 6 cycles.
Study NCT05479240 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: short-range radiotherapy
Description: 5\*5Gy，d1-d5
Study NCT05084118 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: continous application of isotone saline solution for 72 hours
Study NCT06051903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilization wih movement
Description: The purpose of this study is to determine the effect of talar mobilization with movement versus acupuncture on knee pain and function in the postmenopausal women
Study NCT05741398 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VR system by Demaod
Description: non-invasive light pulse generated by a non-contacting device for the treatment of the symptoms of dry eyes and MDG
Study NCT05549791 — intervention group
Intervention type: DRUG
Intervention: Remimazolam Tosilate for Injection
Description: Remimazolam Tosilate for Injection
Study NCT04294030 — intervention group
Intervention type: DEVICE
Intervention: Diagnostic Test: NOWDx HSV-2 Test
Description: For this observational trial, the intervention of interest is the NOWDx HSV-2 Test.
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Given by vein: days 1 and 8 of each Induction cycle; days 1 and 15 of each Consolidation cycle; and day 1of each Maintenance cycle.
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Given by vein: days 1,2,8 and 9 of each Induction cycle; days 1, 2, 8, 9,15, and 16 of each Consolidation cycle; days 1, 2,15, and 16 of each Maintenance cycle.
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given by mouth: days 1-7 of each Induction cycle; days 1-14 of each Consolidation cycle.
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given by mouth or by vein: days 1, 8, 15, and 22 of each Induction cycle; days 1, 8, 15, and 22 of each Consolidation cycle; and days 1 and 15 of every cycle during Maintenance
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given by vein: days 1-4 of each Induction cycle
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epirubicin
Description: Given by vein: days 1-4 of each Induction cycle
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by vein: days 1-4 of each Induction cycle
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given by vein: days 1-4 of each Induction cycle
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given by vein: day -1 of Transplant
Study NCT06140966 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ASCT
Description: day 0 of Transplant
Study NCT06140966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bortezomib
Description: given by subcutaneous injection: days 1, 4, 8, and 11 of pretrial induction chemotherapy
Study NCT05388617 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brera
Description: The applicators will be placed in contact with the skin. The entire defined treatment area will then be treated by delivering energy to the skin. Temperature may be continuously monitored and recorded during treatment. Parameters may be adjusted throughout the treatment to increase subject comfort.
Study NCT06076902 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch (Pitch-Patch Tissue Reinforcement Device))
Description: The Pitch-Patch is a single-use device intended to reinforce the rotator cuff following or during repair by sutures or suture anchors where weakness exists in the soft tissue.
Study NCT06076902 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic rotator cuff reconstruction using fixation with anchors augmented without a synthetic polyester patch
Description: Arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch.
Study NCT06442735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intrapartum ultrasound
Description: In IPUS group, the patient's labor was observed by intrapartum ultrasound.
Study NCT06442735 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: vaginal examination
Description: In VE group, the patient's labor was observed by vaginal examination.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Overcoming Loneliness three-week intervention
Description: A self-guided online loneliness intervention with three 10-20 minute sessions. The intervention content draws heavily from Internet Cognitive Behavioral Therapy for Loneliness and follows the form of single-session mental health interventions.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Overcoming Loneliness single-session intervention
Description: The Overcoming Loneliness Three-Week Intervention condensed into a single-session intervention lasting 20-30 minutes.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Overcoming Loneliness single-session intervention
Description: The Overcoming Loneliness Three-Week Intervention condensed into a single-session intervention lasting 20-30 minutes.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Single-session Sharing Feelings program
Description: A self-guided online supportive therapy intervention with a single 20-30 minute session intended to encourage users to share feelings with close others. Slightly modified from the Sharing Feelings intervention
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Blu Surfer program: a popular online content-based intervention for psychological distress
Description: The Blu Surfer Program is a 25-minute SSI the research team developed centered on popular online content relevant to mental health. In the SSI, the user is first asked to select the kinds of support they would like to view. Next, the user is asked to explore a library of annotated popular online content (filtered by their desired kinds of content) and to select the content they find personally valuable. Finally, the SSI provides the user an annotated list of the content they selected. Users can keep this list to draw from, build on, or share later on as they wish.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The Action Brings Change (ABC) Program (TEAM Lab version)
Description: The ABC project is a 20-30-minute SSI for teens based on behavioral activation. It was found to be efficacious for reducing depression, anxiety, hopelessness, and self-hate and increasing perceived control and agency in youth (link to SSI: https://osf.io/ch2tg/, license: http://creativecommons.org/licenses/by-nc-sa/4.0/). The researchers modified the phrasing in the intervention to make it more relevant to both teens and adults, as the original was designed for only teens.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online help-seeking as usual
Description: This intervention, created by the present research team, aims to emulate how one might find support on their own using the internet. In this condition, participants are asked to browse the internet for 25 minutes to find popular online content relevant to their personal struggles and create an annotated list of links to the content they find useful. The intervention is similar to a self-study condition, which found self-study and a video intervention equally increased mental health knowledge. The survey platform provides text entry boxes to help each participant create their guide and then provides a text version of their guide for them to keep.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Lonely Blu Surfer program: a popular online content-based intervention for loneliness
Description: The Lonely Blu Surfer Program is a 25-minute SSI the research team developed centered on popular online content relevant to loneliness. In the SSI, the user is first asked to select the kinds of support they would like to view. Next, the user is asked to explore a library of annotated popular online content (filtered by their desired kinds of content) and to select the content they find personally valuable. Finally, the SSI provides the user an annotated list of the content they selected. Users can keep this list to draw from, build on, or share later on as they wish.
Study NCT05687162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Overcoming loneliness SSI 8-minute version
Description: A shortened version of an online self-guided intervention based on principles of CBT for loneliness. The research team created this intervention by cutting lengthy didactic material and exercises from the 23-minute version, while maintaining its core concepts.
Study NCT05681702 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin plus clopidogrel
Description: After at least 30 days of DAPT \[with aspirin 81-mg od and a potent P2Y12 inhibitor (prasugrel 10 mg od or ticagrelor 90-mg BID)\] in chronic coronary syndrome or after at least 90 days of DAPT in acute coronary syndromes; patients will continue aspirin and switch to clopidogrel 75-mg.
Study NCT05681702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prasugrel or ticagrelor
Description: After at least 30 days of DAPT \[with aspirin 81-mg od and a potent P2Y12 inhibitor (prasugrel 10 mg od or ticagrelor 90-mg BID)\] in chronic coronary syndrome or after at least 90 days of DAPT in acute coronary syndromes; patients will drop aspirin and continue prasugrel or ticagrelor.
Study NCT04705259 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Antimicrobial Stewardship ENGAGEMENT bundle
Description: Given that a single intervention is unlikely to be effective in stewardship programs, nor in care improvement processes at RACFs \[7\], this trial will deliver a set of multimodal, multidisciplinary interventions to optimise antibiotic use in RACFs. This RACF AMS ENGAGEMENT bundle will comprise the following key interventions:~* Education and engagement of prescribers, nurses, pharmacists and residents and family members~* Nursing initiatives to improve UTI diagnosis and reduce inappropriate urine testing~* Guideline development specific to antibiotic use in RACF residents~* Antimicrobial stewardship team creation in RACF with GP involvement~* EMergency department liaison and use of clinical pathways to ensure consistency of practice across the care continuum~* ElectroNic decision support to guide RACF urine testing and GP antibiotic prescribing~* Telehealth support for key intervention components
Study NCT06078436 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary artery catheter
Description: Pulmonary artery catheter monitoring or not
Study NCT06078436 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter
Description: Pulmonary artery catheter monitoring or not
Study NCT05678634 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Declarative learning with immediate feedback
Description: Children will complete a paired associate learning task on a computer. Each response on half of the blocks will be followed by performance feedback. Feedback will be provided 500 ms following a response (button press)
Study NCT05678634 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Declarative learning with delayed feedback
Description: Children will complete a paired associate learning task on a computer. Each response on half of the blocks will be followed by performance feedback. Feedback will be provided 5000 ms following a response (button press)